2017.08.22
MicroPort® CardioFlow Brings in Strategic Investors – China Renaissance, CICC and HuaTai Securities
Shanghai, China – On August 22, MicroPort Shanghai CardioFlow Medtech Co., Ltd. ("MicroPort®CardioFlow"), a wholly owned subsidiary of Shanghai MicroPort Medical (Group) Co., Ltd. ("MicroPort®"), entered into financing agreements at a consideration of RMB430million and achieved a valuation of RMB2.1 billion after this round of financing.
Read More







沪公网安备 31011502014876号
are registered trademarks of MicroPort CardioFlow Medtech Corporation.